I will put forward (SYNC) Syncronica as my second choice.
This is a recovery stock & was indeed more than £5 earlier this year but now just circa 26p
They had net cash at Jun 30th of £2.6m.
They were going to raise more cash at 50p in October but one big investor pulled out & subsequently it was raised at 30p.
They raised £5.3m & the current market cap is circa £9.8m.
A management shake up has occured with a new CEO & a new focus.
This stock could well double as a recovery stock, a loss is forecast, but they do have an impressive suite of products & their turover was up 80% at the half way stage.
Considering they are trading 10% of so below the last placing price, with some nice buys just moving them up, on the last day of trading before Xmas & options granted to senior management that day too, we might just have seen the bottom.
